Clinical Trial: Trial of Autologous Mesenchymal Stem Cells in Patients With Multiple System Atrophy

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A Double-blind Placebo-controlled Randomized Clinical Trial of Autologous Mesenchymal Stem Cells in Patients With Multiple System Atrophy

Brief Summary: This study is based on positive results in open label trial of mesenchymal stem cells therapy in patients with Multiple System Atrophy (MSA).

Detailed Summary:
Sponsor: Yonsei University

Current Primary Outcome: Scores on unified MSA rating scale [ Time Frame: one month ]

The statistical difference between scores before and after autologous mesenchymal stem cells treatment of unified MSA rating scale will be measured every month and every year using paired t-test.


Original Primary Outcome: Unified MSA rating scale by every month and every year

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Yonsei University

Dates:
Date Received: May 26, 2009
Date Started: May 2008
Date Completion:
Last Updated: August 2, 2011
Last Verified: July 2011